Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioInvent International AB

https://www.bioinvent.com/

Latest From BioInvent International AB

Asia Deal Watch: CStone Partners With LegoChem On Novel ADC Candidate

Plus deals involving Lilly/Daiichi Sankyo, Humianigen/KPM Tech, Telix/China Grand, Appili/Fujifilm, BioInvent/CASI, Osotec/Adel, Neumentum/Nuance, Takeda/HemoShear and Quantum Genomics/Qilu.

Deals Business Strategies

Drug-Coated Balloon For Urethral Strictures Debuts In Europe, Version For BPH Planned

Urotronic set to complete a $20m series C, bringing its total funding to $61m for the development of drug-eluting balloon-based urology products.

Drug Delivery Research & Development

Merrimack Pharma Cutting Jobs Again After Shelving Third Cancer Drug In Year

Merrimack Pharmaceuticals is ending development of its lead drug MM-310 because of safety concerns, triggering a fresh round of job cuts at the troubled Cambridge, Massachusetts-based biotech.

Clinical Trials Drug Safety

BioInvent CEO To Step Down And Seek Scientific Successor

With its focus firmly on oncology, the Swedish biotech, and its outgoing chief, believe the company now needs someone with more scientific skills in the CEO role.

Leadership Sales & Earnings
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Bioinvent Finans AB
UsernamePublicRestriction

Register